Free Trial

Amplifon (OTCMKTS:AMFPF) Trading 1.7% Higher - Time to Buy?

Amplifon logo with Medical background

Amplifon S.p.A. (OTCMKTS:AMFPF - Get Free Report)'s share price traded up 1.7% on Monday . The stock traded as high as $26.45 and last traded at $26.45. 3,160 shares were traded during mid-day trading, an increase of 558% from the average session volume of 480 shares. The stock had previously closed at $26.00.

Analysts Set New Price Targets

Separately, The Goldman Sachs Group upgraded Amplifon to a "hold" rating in a research report on Thursday, December 12th.

Read Our Latest Stock Report on AMFPF

Amplifon Trading Up 1.7 %

The stock has a market cap of $5.96 billion, a PE ratio of 35.74 and a beta of 0.36. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.40 and a current ratio of 0.46. The company's 50-day moving average price is $25.88 and its 200 day moving average price is $29.59.

Amplifon (OTCMKTS:AMFPF - Get Free Report) last posted its earnings results on Wednesday, October 30th. The company reported $0.14 EPS for the quarter. The company had revenue of $623.79 million for the quarter. Amplifon had a return on equity of 15.15% and a net margin of 6.58%.

About Amplifon

(Get Free Report)

Amplifon S.p.A. engages in the distribution of hearing solutions and the fitting of customized products that help people rediscover various emotions of sound in Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company offers Ampli-easy, Ampli-connect, Ampli-energy, and Ampli-mini hearing devices.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Amplifon Right Now?

Before you consider Amplifon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Amplifon wasn't on the list.

While Amplifon currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Transportation Stocks to Watch in 2025: Top Picks for Growth
Crypto Boom 2025: Bitcoin’s Rise and Trump’s Impact on the Market
Goldman Sachs’ 2025 Market Outlook: Top 3 Stock Picks

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines